Cytek Biosciences
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
47215 Lakeview Blvd, Fremont, California...Phone Number
(877) 922-9835Website
www.cytekbio.comRevenue
$204.2 MillionStock Symbol
CTKBIndustry
ZI Rank: 2
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
4
3
4
1
2
2
About Cytek Biosciences
Cytek Biosciences is a leading cell analysis solutions company founded in 1992 and headquartered in Fremont, California with global offices across North America, Europe, and Asia. The company specializes in research and development of advanced cell analysis tools through its patented Full Spectrum Profiling technology. Cytek's product portfolio includes scientific instruments such as the Aurora and Northern Lights systems, cell sorters, reagents, and supporting software that enable high-resolution and high-sensitivity cell analysis for research purposes. The company provides comprehensive solutions for scientific research institutions and laboratories, with its Northern Lights CLC system available for clinical use in China and the European Union. Cytek Biosciences operates in the biotechnology and scientific research services sector, offering both business-to-business and business-to-consumer products through its website cytekbio.com and other distribution channels.Explore more
Cytek Biosciences Org Chart
Get the full picture
Sign in to uncover key details.
DE
Director, Scientific Commercialization
SS
Director, Engineering
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cytek Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Cytek Biosciences launches new products
Funding: Get notified immidiatlly once Cytek Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Cytek Biosciences
Check if Cytek Biosciences has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Cytek Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Cytek Biosciences recently announced quarterly report
Check out if Cytek Biosciences is spiking on competitors!
Click to see if Cytek Biosciences had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Cytek Biosciences
Find 3 more new buyers
Compare Similar Companies to Cytek Biosciences
Compare insights from companies similar to Cytek Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cytek Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Cytek Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cytek Biosciences.
Cytek Biosciences financials insights
Gather financial insights about Cytek Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$2M
Series D
$120M
Cytek Biosciences Tech Stack
A closer look at the technologies used by Cytek Biosciences
Most Recent Scoops
Facilities Relocation / Expansion
Cytek Biosciences has closed its manufacturing facility in Seattle after establishing a new manufacturing facility in Singapore, which operated in parallel with the Seattle facility for most of 2025, eliminating duplicative manufacturing overhead costs with expected gross margin improvement anticipated in 2026.
Facilities Relocation/Expansion, Shut Down, Manufacturing Operations
Project
Cytek Biosciences has introduced the Aurora Evo2, a fully automated flow cytometry system unveiled at the CYTO conference, which automatically powers on, opens its door, loads a plate, runs the experiment, and unloads the plate upon completion, entirely eliminating the need for a technician to operate the system.
Product Launch
Cytek Biosciences has introduced the Cytek Borealis, the industry's first 7-laser, 60-color flow cytometry system.
Product Launch
Product Launch
Cytek Biosciences has introduced the Aurora Evo2 at CYTO, a fully automated flow cytometry system that independently powers on, loads plates, runs experiments, and unloads plates upon completion, eliminating the need for a technician to operate the system.
Product Launch
Person-Based
Research & Development
Cytek Biosciences News & Media
Cytek Biosciences to participate at the Singular Research’s Las Vegas Invitational Conference
FREMONT, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that the company will be participating in the upcoming Singular Research’s Las Vegas Invitational Conference taking place June 14-16, 2026.Cytek Biosciences to Unveil Next-Generation Spectral Flow Cytometry Innovations at CYTO 2026
At CYTO 2026, Cytek will showcase its cell analysis solutions, including the public debut of a new 7-laser Cytek Borealis full spectrum flow cytometer.Cytek CTO exercises RSUs, covers taxes with shares | CTKB Insider Trading - Stock Titan
Cytek Biosciences CTO Yan Ming vested 22,179 RSUs into common stock, with 5,532 shares withheld at $3.55 for taxes, and now directly holds 4,919,617 shares.Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call Transcript
Cytek Biosciences, Inc. (CTKB) Q1 2026 Earnings Call May 7, 2026 4:30 PM EDTCompany ParticipantsPaul Goodson - Head of Investor RelationsWenbin Jiang -...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Cytek Biosciences
Sign Up For FreeTo access detailed company insights
Cytek Biosciences is a leading cell analysis solutions company founded in 1992 and headquartered in Fremont, California with global offices across North America, Europe, and Asia. The company specializes in research and development of advanced cell analysis tools through its patented Full Spectrum Profiling technology. Cytek's product portfolio inc... Read More
